ArticleUrology case reports2026
Penile squamous cell carcinoma masquerading as Fournier's Gangrene: A case of a young patient with aggressive, metastatic disease.
Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fournier's gangrene (FG) is a rapidly progressive necrotizing fasciitis of the perineum and genitals. Although most cases result from polymicrobial infection, rare reports describe secondary causes that mimic FG, including malignancy. We present a man in his forties with clinical and radiographic findings concerning for FG who was ultimately found to have locally advanced, metastatic penile squamous cell carcinoma. This case illustrates that necrotic, infected tumors may masquerade as necrotizing soft-tissue infections, delaying oncologic diagnosis and limiting therapeutic options. Early consideration of underlying malignancy is warranted in atypical, refractory, or rapidly progressive presentations of presumed FG.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.